Dimensional Fund Advisors
ALNA

Dimensional Fund Advisors’s Allena Pharmaceuticals ALNA Stock Holding History

Dimensional Fund Advisors’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23,204
Closed -$37K – 3370
2020
Q2 		$37K Sell
23,204
-39,972
-63% -$67.1K ﹤0.01% 3320
2020
Q1 		$61K Sell
63,176
-5,776
-8% -$11.6K ﹤0.01% 3307
2019
Q4 		$188K Sell
68,952
-5,792
-8% -$19K ﹤0.01% 3266
2019
Q3 		$294K Buy
74,744
+5,776
+8% +$24.8K ﹤0.01% 3230
2019
Q2 		$281K Buy
68,968
+9,087
+15% +$49.6K ﹤0.01% 3275
2019
Q1 		$420K Buy
+59,881
New +$434K ﹤0.01% 3193

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dimensional Fund Advisors's ALNA Position: Q3 2020 in Review

Dimensional Fund Advisors sold out of Allena Pharmaceuticals (ALNA) in Q3 2020, closing a stake of 23,204 shares — an estimated $37K sold.

Dimensional Fund Advisors first reported a position in ALNA in Q1 2019 and held it in 6 quarters. The position peaked at $420K in Q1 2019. 24 funds tracked by Wall St. Rank hold ALNA as of Q3 2020.

  • Dimensional Fund Advisors reported no remaining Allena Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 23,204 Allena Pharmaceuticals shares in Q3 2020, an estimated $37K.
  • Dimensional Fund Advisors first reported a position in Allena Pharmaceuticals in Q1 2019 and held it in 6 quarters.
  • Dimensional Fund Advisors's Allena Pharmaceuticals position peaked at $420K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2020.

Based on Dimensional Fund Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.